Clinical Trials Browser

Phase 2 × Thyroid Neoplasms × famitinib × Clear all

NCT06146985 2023-11-28

Famitinib in Combination With Adebrelimab for the Treatment of Advanced Thyroid Cancer

Phase 2 Unknown

Thyroid Neoplasms